cefcanel daloxate has been researched along with cefaclor anhydrous in 2 studies
| Studies (cefcanel daloxate) | Trials (cefcanel daloxate) | Recent Studies (post-2010) (cefcanel daloxate) | Studies (cefaclor anhydrous) | Trials (cefaclor anhydrous) | Recent Studies (post-2010) (cefaclor anhydrous) |
|---|---|---|---|---|---|
| 10 | 2 | 0 | 919 | 260 | 92 |
| Protein | Taxonomy | cefcanel daloxate (IC50) | cefaclor anhydrous (IC50) |
|---|---|---|---|
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | 7.184 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lionell, C; Magni, L | 1 |
| Köhler, W; Schenk, P | 1 |
1 trial(s) available for cefcanel daloxate and cefaclor anhydrous
| Article | Year |
|---|---|
[Cephalosporin treatment of maxillary sinusitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cephalosporins; Double-Blind Method; Female; Haemophilus Infections; Humans; Male; Maxillary Sinusitis; Middle Aged; Prodrugs | 1995 |
1 other study(ies) available for cefcanel daloxate and cefaclor anhydrous
| Article | Year |
|---|---|
In vivo efficacy of cefcanel daloxate in comparison with cefaclor.
Topics: Absorption; Animals; Bacterial Infections; Cefaclor; Cephalosporins; Disease Models, Animal; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Prodrugs; Staphylococcal Infections | 1990 |